Search Reports :

US Stem Cell Market Analysis

Share |
Publish Date:  May, 2009 No. of Pages: 50
Format: Adobe Reader (PDF) Upto 24 hour delivery
US Stem Cell Market Analysis
  Electronic Access - Single User License   US$ 800.00
  CD-ROM Mail Delivery   US$ 900.00
  Hard Copy Mail Delivery   US$ 1000.00
  Electronic Access - Multi-User License   US$ 1400.00
Description
Table of Content List of Figures & Tables

Stem cell therapy - the emerging therapy area that is drawing the attention of the pharmaceutical players worldwide - refers to the therapy wherein a damaged tissue that cannot heal itself is repaired by the use of stem cell.  The market for stem cells is constantly evolving, with researches going on to exploit the true potential of the market worldwide. Stem cell has emerged as an important market in the US which continues to witness massive investments in this research arena. The US has seen some major achievements in the treatment of the diseases using stem cell technologies. The market has shown remarkable growth since 2005, when the first stem cell product entered into the market. The stem cell therapy market reported a CAGR growth of around 18% in a short period spanning from 2005 to 2008, says our new research report, "US Stem Cell Market Analysis".

The revenue is expected to increase manifold with new stem cell products likely to enter into the market in 2009 and onwards. As the market currently remains in its nascent stage, our team of experts has done thorough analysis of the prevailing trends and developments of the stem cell market in the US. We have studied the US stem cells product market in terms of adult stem cells and embryonic stem cells. This report provides extensive research on the current status and future outlook of these two segments.

We have found that the US embryonic stem cell product market suffered a setback due to the eight year old ban on federal funding of the embryonic stem cells imposed under the Bush Administration. The recent reversal of the ban by Obama on federal funding for the research has opened up new avenues for the market. On technological front, this report studies the stem cells market as therapeutic banking and cellular therapeutics.

The prevalence of the major diseases among people with no permanent cure available and the dependency on medicines for sustainability and well-being provides the ready market for the stem cell companies to tap.

"US Stem Cell Market Analysis" provides extensive research and thorough analysis of the current industry trends driving the growth of stem cell market in the US. This report highlights the emerging segments in the market alongwith their market potential to serve the country’s population. The report will help the clients to understand the market dynamics and get an insight of the current and the future outlook of stem cells market in the US"

Not able to find data you are looking for? Ask our Research Analyst.

All Research Reports

- Healthcare Industry (46)

   - Pharma (16)

   - Biotech (7)

   - Healthcare (17)

   - Vaccine (2)

   - Generics (4)

 

Related Reports

- Saudi Arabian Healthcare ...
- Booming US Generic Drug M...
- US Biotech Market Analysi...
 
Related Research News
Jan 25, 2010
Dec 30, 2009
Nov 15, 2009
Oct 21, 2009
Related Press Releases
Mar 03, 2010
Feb 24, 2010
Feb 22, 2010
Feb 20, 2010
Email Subscription
Receive email alerts of new market research report in your industry.

Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL
Copyright © 2010, RNCOS, 2002-2010
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707